American journal of clinical dermatology
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Amalie Thorsti Møller Rønnstad, Daniel Isufi, Christopher G Bunick, Raj Chovatiya, Mia-Louise Nielsen, Farzad Alinaghi, Simon F Thomsen, Christian Vestergaard, Andreas Wollenberg, Alexander Egeberg, Jacob P Thyssen, Nikolai Loft
Published: 202510.1007/s40257-025-00997-x
Abstract
BACKGROUND: Oral Janus kinase inhibitors (JAKi) have proven effective in the treatment of atopic dermatitis (AD) in multiple clinical trials, providing rapid response, deep efficacy when given at the highest formulated dose, and in the case of abroci…
Preview only. Read the full abstract at the source